458 related articles for article (PubMed ID: 6376025)
1. Insulin secretion and insulin action in non-insulin-dependent diabetes mellitus: which defect is primary?
Reaven GM
Diabetes Care; 1984; 7 Suppl 1():17-24. PubMed ID: 6376025
[TBL] [Abstract][Full Text] [Related]
2. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
Gumbiner B; Polonsky KS; Beltz WF; Griver K; Wallace P; Brechtel G; Henry RR
J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885
[TBL] [Abstract][Full Text] [Related]
3. Abnormalities of insulin pulsatility and glucose oscillations during meals in obese noninsulin-dependent diabetic patients: effects of weight reduction.
Gumbiner B; Van Cauter E; Beltz WF; Ditzler TM; Griver K; Polonsky KS; Henry RR
J Clin Endocrinol Metab; 1996 Jun; 81(6):2061-8. PubMed ID: 8964829
[TBL] [Abstract][Full Text] [Related]
4. Non-insulin-dependent diabetes mellitus: a clinical strategy.
Skyler JS
Diabetes Care; 1984; 7 Suppl 1():118-29. PubMed ID: 6376024
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiology of insulin secretion in non-insulin-dependent diabetes mellitus.
Ward WK; Beard JC; Halter JB; Pfeifer MA; Porte D
Diabetes Care; 1984; 7(5):491-502. PubMed ID: 6094129
[TBL] [Abstract][Full Text] [Related]
6. The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM.
Markovic TP; Jenkins AB; Campbell LV; Furler SM; Kraegen EW; Chisholm DJ
Diabetes Care; 1998 May; 21(5):687-94. PubMed ID: 9589225
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance in non-insulin dependent (type II) and insulin dependent (type I) diabetes mellitus.
Olefsky JM; Revers RR; Prince M; Henry RR; Garvey WT; Scarlett JA; Kolterman OG
Adv Exp Med Biol; 1985; 189():176-205. PubMed ID: 3898763
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of insulin secretion in diabetes mellitus.
Ward WK; Beard JC; Halter JB; Porte D
Adv Exp Med Biol; 1985; 189():137-58. PubMed ID: 3898762
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance, insulin deficiency, and non-insulin-dependent diabetes mellitus.
Cerasi E
Diabetes Res Clin Pract; 1991; 14 Suppl 2():S37-45. PubMed ID: 1794264
[TBL] [Abstract][Full Text] [Related]
10. Toward an integrated phenotype in pre-NIDDM.
Bergman RN; Watanabe R; Rebrin K; Ader M; Steil G
Diabet Med; 1996 Sep; 13(9 Suppl 6):S67-77. PubMed ID: 8894486
[TBL] [Abstract][Full Text] [Related]
11. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
Mandarino LJ; Gerich JE
Diabetes Care; 1984; 7 Suppl 1():89-99. PubMed ID: 6376034
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms for hyperglycemia in type II diabetes mellitus: therapeutic implications for sulfonylurea treatment--an update.
Porte D; Kahn SE
Am J Med; 1991 Jun; 90(6A):8S-14S. PubMed ID: 1872310
[TBL] [Abstract][Full Text] [Related]
13. In vivo beta-cell function at the transition to early non-insulin-dependent diabetes mellitus.
Swinburn BA; Gianchandani R; Saad MF; Lillioja S
Metabolism; 1995 Jun; 44(6):757-64. PubMed ID: 7783660
[TBL] [Abstract][Full Text] [Related]
14. The NSY mouse: a new animal model of spontaneous NIDDM with moderate obesity.
Ueda H; Ikegami H; Yamato E; Fu J; Fukuda M; Shen G; Kawaguchi Y; Takekawa K; Fujioka Y; Fujisawa T
Diabetologia; 1995 May; 38(5):503-8. PubMed ID: 7489831
[TBL] [Abstract][Full Text] [Related]
15. Insulin secretion in obese and non-obese NIDDM.
Cerasi E; Nesher R; Gadot M; Gross D; Kaiser N
Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S27-37. PubMed ID: 8529516
[TBL] [Abstract][Full Text] [Related]
16. Can insulin resistance exist as a primary defect in noninsulin-dependent diabetes mellitus?
Swislocki AL; Donner CC; Fraze E; Chen YD; Reaven GM
J Clin Endocrinol Metab; 1987 Apr; 64(4):778-82. PubMed ID: 3546354
[TBL] [Abstract][Full Text] [Related]
17. Insulin therapy in obese, non-insulin-dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal.
Andrews WJ; Vasquez B; Nagulesparan M; Klimes I; Foley J; Unger R; Reaven GM
Diabetes; 1984 Jul; 33(7):634-42. PubMed ID: 6376219
[TBL] [Abstract][Full Text] [Related]
18. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus.
Eriksson J; Franssila-Kallunki A; Ekstrand A; Saloranta C; Widén E; Schalin C; Groop L
N Engl J Med; 1989 Aug; 321(6):337-43. PubMed ID: 2664520
[TBL] [Abstract][Full Text] [Related]
19. Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus.
Henry RR; Wallace P; Olefsky JM
Diabetes; 1986 Sep; 35(9):990-8. PubMed ID: 3527829
[TBL] [Abstract][Full Text] [Related]
20. Insulin-stimulated glucose disposal in patients with type I (IDDM) and type II (NIDDM) diabetes mellitus.
Reaven GM
Adv Exp Med Biol; 1985; 189():129-36. PubMed ID: 3898761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
